• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外评估术中及术后环境对降低膀胱癌复发的影响。

In vitro assessment of intra-operative and post-operative environment in reducing bladder cancer recurrence.

机构信息

Department of Surgery, S.H. Ho Urology Centre, Prince of Wales Hospital, The Chinese University of Hong Kong, 4/F LCW Clinical Sciences Building, 30-32 Ngan Shing Street, Shatin, New Territories, Hong Kong, China.

Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong, China.

出版信息

Sci Rep. 2022 Jan 7;12(1):22. doi: 10.1038/s41598-021-04035-8.

DOI:10.1038/s41598-021-04035-8
PMID:34997063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8741939/
Abstract

Urinary bladder cancer is a common cancer worldwide. Currently, the modality of treating and monitoring bladder cancer is wide. Nonetheless, the high recurrence rate of non-muscle-invasive bladder cancer after surgical resection is still unsatisfactory. Hereby, our study demonstrated whether the intra-operative and post-operative environments will affect bladder cancer recurrence utilizing in vitro cell line model. Bladder cancer cell lines were submerged in four different irrigating fluids for assessing their tumorigenic properties. Our results showed that sterile water performed the best in terms of the magnitude of cytotoxicity to cell lines. Besides, we also investigated cytotoxic effects of the four irrigating agents as well as mitomycin C (MMC) in normothermic and hyperthermic conditions. We observed that sterile water and MMC had an increased cytotoxic effect to bladder cancer cell lines in hyperthermic conditions. Altogether, our results could be translated into clinical practice in the future by manipulating the intra-operative and post-operative conditions in order to lower the chance of residual cancer cells reimplant onto the bladder, which in turns, reducing the recurrence rate of bladder cancers.

摘要

膀胱癌是一种常见的全球癌症。目前,膀胱癌的治疗和监测方式多种多样。然而,手术后非肌肉浸润性膀胱癌的高复发率仍然不尽如人意。因此,我们的研究利用体外细胞系模型证明了手术过程中和手术后的环境是否会影响膀胱癌的复发。膀胱癌细胞系被浸入四种不同的灌洗液中,以评估它们的致瘤特性。我们的结果表明,无菌水在细胞系的细胞毒性大小方面表现最佳。此外,我们还研究了四种灌洗液以及丝裂霉素 C(MMC)在常温与高温条件下的细胞毒性作用。我们观察到,在高温条件下,无菌水和 MMC 对膀胱癌细胞系的细胞毒性作用增强。总之,我们的研究结果可以通过操纵手术过程中和手术后的条件转化为临床实践,以降低残留癌细胞重新植入膀胱的机会,从而降低膀胱癌的复发率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b9/8741939/2022e702268a/41598_2021_4035_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b9/8741939/34d4aed43580/41598_2021_4035_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b9/8741939/1fb37564961e/41598_2021_4035_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b9/8741939/00a14b5ba50c/41598_2021_4035_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b9/8741939/347628b760db/41598_2021_4035_Fig4a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b9/8741939/2022e702268a/41598_2021_4035_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b9/8741939/34d4aed43580/41598_2021_4035_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b9/8741939/1fb37564961e/41598_2021_4035_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b9/8741939/00a14b5ba50c/41598_2021_4035_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b9/8741939/347628b760db/41598_2021_4035_Fig4a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0b9/8741939/2022e702268a/41598_2021_4035_Fig5_HTML.jpg

相似文献

1
In vitro assessment of intra-operative and post-operative environment in reducing bladder cancer recurrence.体外评估术中及术后环境对降低膀胱癌复发的影响。
Sci Rep. 2022 Jan 7;12(1):22. doi: 10.1038/s41598-021-04035-8.
2
Bladder intracavitary hyperthermic perfusion chemotherapy for the prevention of recurrence of non-muscle invasive bladder cancer after transurethral resection.膀胱腔内热灌注化疗预防经尿道切除术后非肌层浸润性膀胱癌复发
Oncol Rep. 2017 May;37(5):2761-2770. doi: 10.3892/or.2017.5570. Epub 2017 Apr 11.
3
Continuous Saline Bladder Irrigation in Reducing Recurrence and Progression When Compared to Immediate Mitomycin- C Instillation Post- Resection of Bladder Tumor: A Short Communication.连续生理盐水膀胱冲洗与即刻丝裂霉素 C 膀胱灌注在减少膀胱肿瘤切除术后复发和进展方面的比较:一项简短交流。
Asian Pac J Cancer Prev. 2022 Jan 1;23(1):171-175. doi: 10.31557/APJCP.2022.23.1.171.
4
Cystectomy outcomes in patients who have failed Radiofrequency-induced Thermo-chemotherapeutic Effect Mitomycin-C (RITE-MMC) treatment for high-risk non-muscle invasive bladder cancer (HRNMIBC)-Does it complicate surgery and adversely impact oncological outcome?对于接受过丝裂霉素 C(MMC)射频热化学诱导治疗(RITE-MMC)治疗失败的高危非肌肉浸润性膀胱癌(HRNMIBC)患者,膀胱切除术的结果如何——是否会使手术复杂化并对肿瘤学结果产生不利影响?
Urol Oncol. 2021 May;39(5):300.e15-300.e20. doi: 10.1016/j.urolonc.2020.09.016. Epub 2020 Oct 6.
5
[Comparison of the effectiveness between long-term instillation of mitomycin C and short-term prophylaxis with MMC or bacille Calmette-Guérin. Study of patients with non-muscle-invasive urothelial cancer of the urinary bladder].[膀胱非肌层浸润性尿路上皮癌患者长期丝裂霉素C灌注与丝裂霉素C或卡介苗短期预防效果的比较研究]
Urologe A. 2008 May;47(5):608-15. doi: 10.1007/s00120-008-1671-z.
6
Effectivity of intravescical thermo-chemotherapy prophylaxis for patients with high recurrence and progression risk for non-muscle invasive bladder cancer.膀胱内热化疗预防对非肌层浸润性膀胱癌高复发和进展风险患者的有效性。
Arch Ital Urol Androl. 2017 Jun 30;89(2):102-105. doi: 10.4081/aiua.2017.2.102.
7
The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.膀胱T1期肿瘤患者接受膀胱内丝裂霉素治疗后重复经尿道切除术对复发率和进展率的影响:一项前瞻性随机临床试验。
J Urol. 2006 May;175(5):1641-4. doi: 10.1016/S0022-5347(05)01002-5.
8
[Study of the synergy of microwave hyperthermia/intravesical chemotherapy in the prevention of recurrences of superficial tumors of the bladder].[微波热疗/膀胱内化疗协同预防膀胱浅表肿瘤复发的研究]
Prog Urol. 1999 Feb;9(1):69-80.
9
Long-term experience with early single mitomycin C instillations in patients with low-risk non-muscle-invasive bladder cancer: prospective, single-centre randomised trial.早期单剂量丝裂霉素 C 膀胱灌注治疗低危非肌层浸润性膀胱癌的长期经验:前瞻性、单中心随机试验。
World J Urol. 2011 Aug;29(4):517-21. doi: 10.1007/s00345-011-0691-2. Epub 2011 May 19.
10
Single-dose perioperative mitomycin-C versus thiotepa for low-grade noninvasive bladder cancer.围手术期单剂量丝裂霉素-C与噻替派治疗低度非侵袭性膀胱癌的比较
Can J Urol. 2019 Oct;26(5):9922-9930.

引用本文的文献

1
Therapeutic Potential of Regorafenib in Cisplatin-Resistant Bladder Cancer with High Epithelial-Mesenchymal Transition and Stemness Properties.雷戈非尼在具有高上皮-间充质转化和干性特征的顺铂耐药膀胱癌中的治疗潜力。
Int J Mol Sci. 2023 Dec 18;24(24):17610. doi: 10.3390/ijms242417610.
2
Recurrence mechanisms of non-muscle-invasive bladder cancer - a clinical perspective.非肌肉浸润性膀胱癌的复发机制——临床视角。
Nat Rev Urol. 2022 May;19(5):280-294. doi: 10.1038/s41585-022-00578-1. Epub 2022 Mar 31.

本文引用的文献

1
Impact of Adjuvant Chemotherapy on Survival of Patients with Advanced Residual Disease at Radical Cystectomy following Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis.新辅助化疗后辅助化疗对根治性膀胱切除术后晚期残留疾病患者生存的影响:系统评价和荟萃分析
J Clin Med. 2021 Feb 8;10(4):651. doi: 10.3390/jcm10040651.
2
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel.欧洲泌尿外科学会(EAU)非肌肉浸润性膀胱癌(NMIBC)预后因素风险组,纳入世界卫生组织 2004/2016 年和世界卫生组织 1973 年分级系统:EAU NMIBC 指南小组的更新。
Eur Urol. 2021 Apr;79(4):480-488. doi: 10.1016/j.eururo.2020.12.033. Epub 2021 Jan 6.
3
Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomes.经尿道膀胱肿瘤切除术治疗非肌肉浸润性膀胱癌后延迟卡介苗免疫治疗的起始时间与不良生存结局相关。
World J Urol. 2021 Jul;39(7):2545-2552. doi: 10.1007/s00345-020-03522-3. Epub 2020 Nov 23.
4
Global Trends of Bladder Cancer Incidence and Mortality, and Their Associations with Tobacco Use and Gross Domestic Product Per Capita.膀胱癌发病率和死亡率的全球趋势,及其与烟草使用和人均国内生产总值的关系。
Eur Urol. 2020 Dec;78(6):893-906. doi: 10.1016/j.eururo.2020.09.006. Epub 2020 Sep 21.
5
Hyperthermic therapy using warm sterile water enhances cytocidal effects on bladder cancer cells.温热无菌水疗法增强了膀胱癌细胞的细胞毒性作用。
Scand J Urol. 2020 Feb;54(1):65-69. doi: 10.1080/21681805.2019.1708967. Epub 2020 Jan 13.
6
Transient Mitomycin C-treatment of human corneal epithelial cells and fibroblasts alters cell migration, cytokine secretion, and matrix accumulation.短暂丝裂霉素 C 处理人角膜上皮细胞和纤维母细胞可改变细胞迁移、细胞因子分泌和基质积累。
Sci Rep. 2019 Sep 25;9(1):13905. doi: 10.1038/s41598-019-50307-9.
7
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
8
Comparison of sterile water irrigation versus intravesical mitomycin C in preventing recurrence of nonmuscle invasive bladder cancer after transurethral resection.无菌水冲洗与膀胱内灌注丝裂霉素C预防经尿道切除术后非肌层浸润性膀胱癌复发的比较。
Indian J Urol. 2017 Apr-Jun;33(2):144-148. doi: 10.4103/iju.IJU_371_16.
9
Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?经尿道切除术后即刻单次灌注化疗与单纯经尿道切除治疗膀胱 pTa-pT1 期尿路上皮癌的随机对照试验的系统评价和个体患者数据分析:哪些患者从中获益?
Eur Urol. 2016 Feb;69(2):231-44. doi: 10.1016/j.eururo.2015.05.050. Epub 2015 Jun 16.
10
In-vitro cytocidal effect of water on bladder cancer cells: The potential role for intraperitoneal lavage during radical cystectomy.水对膀胱癌细胞的体外杀细胞作用:根治性膀胱切除术期间腹腔灌洗的潜在作用。
Can Urol Assoc J. 2015 Mar-Apr;9(3-4):E109-13. doi: 10.5489/cuaj.2435.